DEAD

Serial Number

77167128

Owner

REVO BIOLOGICS, INC

Attorney

Cynthia J. Walden

First Use Date

Apr 13, 2007

Filing Date

Apr 27, 2007

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GTC BIOTHERAPEUTICS Trademark

Serial Number: 77167128 • Registration: 3391128

GTC BIOTHERAPEUTICS is a trademark filed by REVO BIOLOGICS, INC on April 27, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

REVO BIOLOGICS, INC (5 trademarks)

FRAMINGHAM, MA 01702

Entity Type: 03

GTC Biotherapeutics, Inc. (7 trademarks)

175 Crossing Boulevard
Framingham, MA 017019322

Entity Type: 03

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, S.A. (2 trademarks)

3 AVENUE DES TROPIQUES
LES ULIS 91940 , FR

Entity Type: 99

Legal Representation

Attorney of Record

Cynthia J. Walden

228 trademarks filed View all →

Trademark Details

Filing Date

April 27, 2007

Registration Date

March 4, 2008

First Use Anywhere

April 13, 2007

First Use in Commerce

April 13, 2007

Published for Opposition

December 18, 2007

Cancellation Date

October 5, 2018

Goods & Services

diagnostic and therapeutic products derived from the milk of transgenic animals, namely, antithrombin for diagnostic and therapeutic use in the treatment of hereditary deficiency of antithrombin

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Oct 5, 2018 CAEX

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Mar 4, 2017 REM2

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 9, 2014 ASGN

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 22, 2014 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 22, 2014 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 22, 2014 APRE

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Mar 5, 2014 ASGN

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Mar 4, 2014 815F

TEAS SECTION 8 & 15 RECEIVED

Mar 4, 2014 E815

REGISTERED-PRINCIPAL REGISTER

Mar 4, 2008 R.PR

PUBLISHED FOR OPPOSITION

Dec 18, 2007 PUBO

NOTICE OF PUBLICATION

Nov 28, 2007 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Nov 15, 2007 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 14, 2007 CNSA

AMENDMENT FROM APPLICANT ENTERED

Oct 25, 2007 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 25, 2007 CRFA

ASSIGNED TO LIE

Oct 25, 2007 ALIE

PAPER RECEIVED

Sep 17, 2007 MAIL

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 30, 2007 GNRN

NON-FINAL ACTION E-MAILED

Jun 30, 2007 GNRT

NON-FINAL ACTION WRITTEN

Jun 30, 2007 CNRT

ASSIGNED TO EXAMINER

Jun 30, 2007 DOCK

NOTICE OF DESIGN SEARCH CODE MAILED

May 2, 2007 MDSC

NEW APPLICATION ENTERED

May 1, 2007 NWAP

Related Trademarks

More from this Owner

REVO BIOLOGICS

ATRYN ANTITHROMBIN (RECOMBINANT)

GTC BIOTHERAPEUTICS

GTC BIO

More in Same Class

Serial #77167085